Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration

Mehmet AgilliDepartment of Biochemistry, Agri Military Hospital, Agri, Turkey, Correspondence[email protected]

, MD,

Fevzi Nuri AydinDepartment of Biochemistry, Sirnak Military Hospital, Sirnak, Turkey, and

, MD,

Tuncer CayciDepartment of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey

, MD &

Yasemin Gulcan KurtDepartment of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey

, MD

References

Min JK, Kim J, Woo JM. Elevated plasma pentraxin3 levels and its association with neovascular age-related macular degeneration. Ocul Immunol Inflamm. 2015;23:205–211
PubMed Web of Science ®Google Scholar
Yaman H, Cakir E, Akgul EO, et al. Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury. Exp Toxicol Pathol. 2013;65:147–151
PubMed Web of Science ®Google Scholar
Bonacina F, Baragetti A, Catapano AL, Norata GD. Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases. Mediators Inflamm. 2013;2013:725102
PubMed Web of Science ®Google Scholar
Rosjo E, Myhr KM, Loken-Amsrud KI, et al. Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. J Neuroimmunol. 2014;271:60–65
PubMed Web of Science ®Google Scholar
Lee JS, Kim J. Factors affecting the use of dietary supplements by Korean adults: data from the Korean National Health and Nutrition Examination Survey III. J Am Diet Assoc. 2009;109:1599–1605
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date